Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Homoarginine and blood pressure: a 10-year prospective relationship in normotensives

Subjects

Abstract

Nitric oxide plays a major role in the regulation of blood pressure, and impaired nitric oxide bioavailability contributes to the development of hypertension (HT). Various factors may contribute to nitric oxide bioavailability—including availability of the substrate for nitric oxide synthesis, L-arginine and its homolog L-homoarginine. We investigated whether blood pressure after 10 years associates with baseline L-homoarginine in participants who remained normotensive (NT) or developed HT, respectively. Data from the South African leg of the Prospective Urban and Rural Epidemiology study, performed in the North-West Province, were used. We investigated participants who either remained NT (N = 166) or who developed HT (N = 166) over 10 years. Blood pressure was measured with validated OMRON devices and serum L-homoarginine was analyzed with liquid chromatography-tandem mass spectrometry. L-homoarginine levels were similar at baseline (p = 0.39) and follow-up (p = 0.93) between NT and hypertensive groups. In the group that remained NT after 10 years, baseline L-homoarginine correlated positively with follow-up brachial systolic blood pressure (adj.R2 = 0.13; β = 0.33; p= 0.001), brachial pulse pressure (adj.R2= 0.15 β = 0.40; p = 0.001), and central pulse pressure (adj.R2= 0.20; β = 0.30; p = 0.003). No significant associations were found in the group that developed HT after 10 years. We found a positive, independent association between blood pressure and L-homoarginine in a group that remained NT, but not in a group that developed HT after 10 years. This may suggest a protective role for L-homoarginine to maintain normal blood pressure, but only to a certain level. Once HT develops other factors may overshadow the protective effects of L-homoarginine.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2: Relationship of follow-up blood pressure measures with baseline L-homoarginine.
Fig. 3: Associations between follow-up blood pressure measures and baseline L-homoarginine in total group, participants that remained normotensive or became hypertensive, respectively, over 10 years.

Similar content being viewed by others

References

  1. Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of undiagnosed hypertension in sub-saharan Africa: a systematic review and meta-analysis. Hypertension. 2015;65:291–8.

    Article  CAS  Google Scholar 

  2. Kengne AP, Ntyintyane LM, Mayosi BM. A systematic overview of prospective cohort studies of cardiovascular disease in sub-Saharan Africa. Cardiovasc J Afr. 2012;23:103.

    Article  Google Scholar 

  3. Dominiczak AF, Bohr DF. Nitric oxide and its putative role in hypertension. Hypertension. 1995;25:1202–11.

    Article  CAS  Google Scholar 

  4. Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R, et al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol. 2003;23:1455–9.

    Article  CAS  Google Scholar 

  5. Schlaich MP, Parnell MM, Ahlers BA, Finch S, Marshall T, Zhang W-Z, et al. Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects. Circulation. 2004;110:3680–6.

    Article  CAS  Google Scholar 

  6. Böger RH. Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials. Vasc Med. 2005;10:S19–25.

    Article  Google Scholar 

  7. Bode-Böger SM, Scalera F, Kielstein JT, Martens-Lobenhoffer J, Breithardt G, Fobker M, et al. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol. 2006;17:1128–34.

    Article  Google Scholar 

  8. Valtonen P, Laitinen T, Lyyra-Laitinen T, Raitakari OT, Juonala M, Viikari JS, et al. Serum L-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation. Circ J. 2008;72:1879–84.

    Article  CAS  Google Scholar 

  9. Moali C, Boucher JL, Sari MA, Stuehr DJ, Mansuy D. Substrate specificity of NO synthases: detailed comparison of l-arginine, homo-l-arginine, their N ω-hydroxy derivatives, and N ω-hydroxynor-l-arginine. Biochemistry. 1998;37:10453–60.

    Article  CAS  Google Scholar 

  10. Kakoki M, Kim HS, Edgell CJS, Maeda N, Smithies O, Mattson DL. Amino acids as modulators of endothelium-derived nitric oxide. Am J Physiol Ren Physiol. 2006;291:F297–304.

    Article  CAS  Google Scholar 

  11. Hrabak A, Bajor T, Temesi A. Comparison of substrate and inhibitor specificity of arginase and nitric oxide (NO) synthase for arginine analogs and related compounds in murine and rat macrophages. Biochem Biophys Res Commun. 1994;198:206–12.

    Article  CAS  Google Scholar 

  12. Reczkowski RS, Ash DE. Rat liver arginase: kinetic mechanism, alternate substrates, and inhibitors. Arch Biochem Biophys. 1994;312:31–7.

    Article  CAS  Google Scholar 

  13. Tommasi S, Elliot DJ, Da Boit M, Gray SR, Lewis BC, Mangoni AA. Homoarginine and inhibition of human arginase activity: kinetic characterization and biological relevance. Sci Rep. 2018;8:1–13.

    CAS  Google Scholar 

  14. van der Zwan LP, Davids M, Scheffer PG, Dekker JM, Stehouwer CD, Teerlink T. L-homoarginine and L-arginine are antagonistically related to blood pressure in an elderly population: the Hoorn study. J Hypertens. 2013;31:1114–23.

    Article  Google Scholar 

  15. Pilz S, Teerlink T, Scheffer PG, Meinitzer A, Rutters F, Tomaschitz A, et al. Homoarginine and mortality in an older population: the Hoorn study. Eur J Clin Investig. 2014;44:200–8.

    Article  CAS  Google Scholar 

  16. Kayacelebi AA, Nguyen TH, Neil C, Horowitz JD, Jordan J, Tsikas D. Homoarginine and 3-nitrotyrosine in patients with takotsubo cardiomyopathy. Int J Cardiol. 2014;173:546–7.

    Article  Google Scholar 

  17. Seedat Y, Rayner B, Veriava Y. South African hypertension practice guideline 2014. Cardiovasc J Afr. 2014;25:288.

    Article  CAS  Google Scholar 

  18. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press. 2013;22:193–278.

    Article  Google Scholar 

  19. Marfell-Jones MJ, Stewart AD, de Ridder JH. International standardsfor anthropometric assessment. Lower Hutt, New Zealand. 2012.

  20. Atzler D, Mieth M, Maas R, Böger RH, Schwedhelm E. Stable isotope dilution assay for liquid chromatography–tandem mass spectrometric determination of l-homoarginine in human plasma. J Chromatogr B. 2011;879:2294–8.

    Article  CAS  Google Scholar 

  21. Schwedhelm E, Maas R, Tan-Andresen J, Schulze F, Riederer U, Böger RH. High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma. J Chromatogr B. 2007;851:211–9.

    Article  CAS  Google Scholar 

  22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.

    Article  CAS  Google Scholar 

  23. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20–9.

    Article  CAS  Google Scholar 

  24. Stuehr DJ. Enzymes of the L-arginine to nitric oxide pathway. J Nutr. 2004;134:2748S–51S.

    Article  CAS  Google Scholar 

  25. El‐Bassossy HM, El‐Fawal R, Fahmy A, Watson ML. Arginase inhibition alleviates hypertension in the metabolic syndrome. Br J Pharmacol. 2013;169:693–703.

    Article  Google Scholar 

Download references

Acknowledgements

We acknowledge all participants of the PURE study as well as the students, support staff, and researchers at the Hypertension Research and Training Clinic at the North-West University. In addition, the supporting staff in the Africa Unit for Transdisciplinary Health Research (AUTHeR), Dr. Iolanthé Kruger, North-West University, South Africa, as well as Dr. S. Yusuf (PURE-International) and the PURE project staff at the PHRI, Hamilton Health Sciences and McMaster University, ON, Canada.

Funding

This work was financially supported by SANPAD (South Africa–Netherlands Research Program on Alternatives in Development), PHRI (Population Health Research Institute), the MRC (Medical Research Council) of South Africa, the South African NRF (National Research Foundation) (GUN numbers 2069139 and FA2006040700010), the North-West University, Roche Diagnostics, and the German Academic Exchange Service (DAAD)-NRF. Opinions expressed and conclusions arrived at are those of the author and are not necessarily to be attributed to the DAAD-NRF.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Catharina Martha Cornelia Mels.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mokhaneli, M.C., Botha-Le Roux, S., Fourie, C.M.T. et al. Homoarginine and blood pressure: a 10-year prospective relationship in normotensives. J Hum Hypertens 36, 135–143 (2022). https://doi.org/10.1038/s41371-020-00449-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-020-00449-5

Search

Quick links